Search

Your search keyword '"Rampling, T"' showing total 91 results

Search Constraints

Start Over You searched for: Author "Rampling, T" Remove constraint Author: "Rampling, T"
91 results on '"Rampling, T"'

Search Results

1. Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2. Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

4. Genomic investigations of unexplained acute hepatitis in children

5. Genomic investigations of unexplained acute hepatitis in children

7. Neonatal Monkeypox Virus Infection

8. COVAC1 phase 2a expanded safety and immunogenicity study of a self-amplifying RNA vaccine against SARS-CoV-2

9. Low seropositivity and sub-optimal neutralisation rates in patients fully vaccinated against COVID-19 with B cell malignancies

11. Novel viral vector vaccines for tropical infections

12. Safety and efficacy of novel malaria vaccine regimens of RTS, S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

13. CXCR3+ T Follicular Helper Cells Induced by Co-Administration of RTS,S/AS01B and Viral-Vectored Vaccines Are Associated With Reduced Immunogenicity and Efficacy Against Malaria

14. Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with chimpanzee adenovirus 63 and modified vaccinia ankara vectored vaccines expressing ME-TRAP

15. A monovalent chimpanzee adenovirus Ebola vaccine — preliminary report

16. Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

17. Evaluating controlled human malaria infection in Kenyan adults with varying degrees of prior exposure to Plasmodium falciparum using sporozoites administered by intramuscular injection

18. Safety and High Level Efficacy of the Combination Malaria Vaccine Regimen of RTS,S/AS01B with ChAd-MVA Vectored Vaccines Expressing ME-TRAP

19. Demonstration of the blood-stage controlled human malaria infection model to assess efficacy of the Plasmodium falciparum AMA1 vaccine FMP2.1/AS01

20. Safety and high level efficacy of the combination malaria vaccine regimen of RTS,S/AS01B with ChAd-MVA vectored vaccines expressing ME-TRAP

21. Clinical utility and long-term use of atazanavir in the treatment of HIV-1 infection

22. Evaluation of the efficacy of ChAd63-MVA vectored vaccines expressing CS & ME-TRAP against controlled human malaria infection in malaria naïve individuals

23. Evaluation of the Efficacy of ChAd63-MVA Vectored Vaccines Expressing Circumsporozoite Protein and ME-TRAP Against Controlled Human Malaria Infection in Malaria-Naive Individuals

24. A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA.

27. Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral Fluid

31. Evaluation of a multiplexed immunoassay for assessing long-term humoral immunity Orthopoxviruses.

32. Investigation of a Human Case of Francisella tularensis Infection, United Kingdom, 2023.

33. A Cross-Sectional Evaluation of the Virtual Outpatient Management of People With Mpox.

34. Anti-inflammatory therapy with nebulized dornase alfa for severe COVID-19 pneumonia: a randomized unblinded trial.

35. Histopathological findings from the investigation of paediatric acute hepatitis of unknown aetiology, United Kingdom 2022.

36. Paediatric acute hepatitis of unknown aetiology: a national investigation and adenoviraemia case-control study in the UK.

37. Monkeypox virus-infected individuals mount comparable humoral immune responses as Smallpox-vaccinated individuals.

38. Review and Consultations of Canadian Financial Education Programs for Individuals with Disabilities.

39. Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial.

40. Use of cidofovir in a patient with severe mpox and uncontrolled HIV infection.

41. Imported rickettsial infections to the United Kingdom, 2015-2020.

42. Corrigendum to "Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial" [J Infect 84(6) (2022) 795-813, 5511].

43. Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study.

44. Genomic investigations of unexplained acute hepatitis in children.

45. Comparison of new and emerging SARS-CoV-2 variant transmissibility through active contact testing. A comparative cross-sectional household seroprevalence study.

47. Neonatal Monkeypox Virus Infection.

49. Demographics and Outcomes of Initial Phase of COVID-19 Medicines Delivery Units Across 4 UK Centers During Peak B1.1.529 Omicron Epidemic: A Service Evaluation.

Catalog

Books, media, physical & digital resources